Adicet Bio Statistics
Total Valuation
Adicet Bio has a market cap or net worth of $80.21 million. The enterprise value is -$103.66 million.
Important Dates
The next estimated earnings date is Tuesday, March 18, 2025, after market close.
| Earnings Date | Mar 18, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Adicet Bio has 82.40 million shares outstanding. The number of shares has increased by 76.93% in one year.
| Current Share Class | 82.40M |
| Shares Outstanding | 82.40M |
| Shares Change (YoY) | +76.93% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 45.67% |
| Float | 61.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.64, with a Debt / Equity ratio of 0.09.
| Current Ratio | 10.64 |
| Quick Ratio | 10.43 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42,812.67 |
Financial Efficiency
Return on equity (ROE) is -58.04% and return on invested capital (ROIC) is -35.98%.
| Return on Equity (ROE) | -58.04% |
| Return on Assets (ROA) | -33.50% |
| Return on Invested Capital (ROIC) | -35.98% |
| Return on Capital Employed (ROCE) | -56.69% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$824,364 |
| Employee Count | 143 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.85% in the last 52 weeks. The beta is 1.64, so Adicet Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.64 |
| 52-Week Price Change | -65.85% |
| 50-Day Moving Average | 0.94 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 52.71 |
| Average Volume (20 Days) | 1,568,732 |
Short Selling Information
The latest short interest is 2.97 million, so 3.61% of the outstanding shares have been sold short.
| Short Interest | 2.97M |
| Short Previous Month | 3.06M |
| Short % of Shares Out | 3.61% |
| Short % of Float | 4.87% |
| Short Ratio (days to cover) | 8.37 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -128.44M |
| Pretax Income | -139.79M |
| Net Income | -117.88M |
| EBITDA | -121.90M |
| EBIT | -128.44M |
| Earnings Per Share (EPS) | -$1.55 |
Full Income StatementBalance Sheet
The company has $202.07 million in cash and $18.20 million in debt, giving a net cash position of $183.87 million or $2.23 per share.
| Cash & Cash Equivalents | 202.07M |
| Total Debt | 18.20M |
| Net Cash | 183.87M |
| Net Cash Per Share | $2.23 |
| Equity (Book Value) | 211.53M |
| Book Value Per Share | 2.57 |
| Working Capital | 186.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$91.76 million and capital expenditures -$1.08 million, giving a free cash flow of -$92.84 million.
| Operating Cash Flow | -91.76M |
| Capital Expenditures | -1.08M |
| Free Cash Flow | -92.84M |
| FCF Per Share | -$1.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |